US 7,507,841 B2
Cannabinoid receptor modulator
Shigenori Ohkawa, Osaka (Japan); Tetsuya Tsukamoto, Osaka (Japan); Yoshihiro Kiyota, Osaka (Japan); Mika Goto, Osaka (Japan); Shouzou Yamamoto, Osaka (Japan); Masato Shimojou, Osaka (Japan); and Masaki Setou, Osaka (Japan)
Assigned to Takeda Pharmaceutical Company Limited, Osaka (Japan)
Filed on Jul. 11, 2007, as Appl. No. 11/822,941.
Application 11/822941 is a division of application No. 10/561483, filed on Dec. 20, 2005.
Claims priority of application No. 2003-182039 (JP), filed on Jun. 26, 2003.
Prior Publication US 2008/0021087 A1, Jan. 24, 2008
Int. Cl. C07D 307/76 (2006.01)
U.S. Cl. 549—496 2 Claims
 
1. (+)-N-((3R)-7-(1-hydroxyethyl)-3-(4-isopropylphenyl)-4,6-dimethyl-2,3-dihydro-1-benzofuran-5-yl)-3,3-dimethylbutanamide or a salt thereof.